Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Oncology Reports|December 24, 2024
Bcl‑xL‑specific BH3 mimetic A‑1331852 suppresses proliferation of fluorouracil‑resistant colorectal cancer cells by inducing apoptosisAkira Kato, Hiroki Takahashi, Hiroyuki Asai, et al.
Physiological Reports|March 26, 2023
Boric acid transport activity of marine teleost aquaporins expressed in Xenopus oocytesShiori Kumagai, Erika Watanabe, Naoko Hayashi, et al.
Cell Reports|February 28, 2019
Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in GlioblastomaMelissa Ranjit, Masaki Hirano, Kosuke Aoki, et al.
The European Journal of Neuroscience|November 1, 2007
Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestrationKazuyuki Takata, Chiho Hirata-Fukae, Amanda G Becker, et al.
Journal of Pharmacological Sciences|September 5, 2009
Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain modelsKazuhisa Minami, Minoru Hasegawa, Hisanori Ito, et al.
The Journal of Pathology|September 10, 2017
Significance of perivascular tumour cells defined by CD109 expression in progression of gliomaYukihiro Shiraki, Shinji Mii, Atsushi Enomoto, et al.
Brain Tumor Pathology|November 26, 2021
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomasTomohide Nishikawa, Reiko Watanabe, Yotaro Kitano, et al.
Iscience|March 1, 2021
<i>Neurod4</i> converts endogenous neural stem cells to neurons with synaptic formation after spinal cord injuryToshiki Fukuoka, Akira Kato, Masaki Hirano, et al.
Journal of Pain & Palliative Care Pharmacotherapy|December 1, 2011
Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine, and fentanylAtsushi Nakamura, Minoru Hasegawa, Hisanori Ito, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2025
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8Paul T Scott, Jayani Pathirana, Akira Kato, et al.
Pageof 19